| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Zenas BioPharma, Inc.
13G/A
Amendment 1
ZBIO · 98937L105
|
10.4% |
9/8/2026
Event 8/26/2026
|
|||
| InnoCare Pharma Inc. | 10.4% | ||||
| Ocean Prominent Limited | 10.4% | ||||
| InnoCare Pharma Limited | 10.4% | ||||
|
Zenas BioPharma, Inc.
13G
ZBIO · 98937L105
|
9.4% |
10/15/2025
Event 10/7/2025
|
|||
| InnoCare Pharma Inc. | 9.4% | ||||
| Ocean Prominent Limited | 9.4% | ||||
| InnoCare Pharma Limited | 9.4% | ||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.